Dopamine agonists, anti-progestins, anti-androgens, long-term-release GnRH agonists and anti-estrogens in canine reproduction: A review

Theriogenology

Volumn 66, Issue 6-7, 2006, Pages 1560-1567

  Gobello, C ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Anti androgen; Anti estrogen; Anti progestin; Dog; Dopamine agonist; Long term release GnRH agonist

Indexed keywords

ANTIANDROGEN; ANTIESTROGEN; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; GONADORELIN;

ANIMAL; ARTICLE; DELAYED RELEASE FORMULATION; DOG; DRUG EFFECT; DRUG POTENTIATION; FEMALE; MALE; PHYSIOLOGY; REPRODUCTION;

ANDROGEN ANTAGONISTS; ANIMALS; DELAYED-ACTION PREPARATIONS; DOGS; DOPAMINE AGONISTS; ESTROGEN ANTAGONISTS; FEMALE; GONADOTROPIN-RELEASING HORMONE; MALE; REPRODUCTION;

CANIS FAMILIARIS;

EID: 33748541065     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2006.02.005     Document Type: Article

References (77)

1. Fieni F., Verstegen J., Heraud V., and Onclin K. Physiologie de la prolactine, pharmacologie des antiprolactiniques et applications chez la chienne. Prat Med Chir Anim Comp 34 (1999) 187-199
2. Ascoli M., and Segaloff D. Adenohypophysis hormones and their releasing factors. In: Herdman J.J., Limbird L.E., and Goodman Gilman A. (Eds). Goodman and Gilman's: the pharmacological basis of therapeutics. 9th ed. (1996), Goodman & Gilman, New York 1447-1468
3. Jochle W., Arbeiter K., Post K., Ballabio R., and D'Ver A.S. Effects of pseudopregnancy, pregnancy and interoestrus intervals of pharmacological suppression of prolactin secretion in female dogs and cats. J Reprod Fertil 39 (1989) 199-207
4. Gobello C., Sota L.D., and Goya R.G. Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches. Anim Reprod Sci 66 (2001) 257-267
5. Janssens L.A. Treatment of pseudopregnancy with bromocriptine, an ergot alkaloid. Vet Rec 119 (1986) 172-174
6. Mialot J.P., Lagneau F., Chaffaux S., and Badinand F. Inhibition de la lactation de la pseudogestation chez la chienne par la bromocryptine. Rec Med Vet 157 (1981) 351-365
7. Okkens A.C., Dieleman S.J., Kooistra H.S., and Bevers M.M. Plasma concentrations of prolactin in overtly pseudopregnant Afghan hounds and the effect of metergoline. J Reprod Fertil Suppl 51 (1997) 295-301
8. Okkens A.C., Bevers M.M., Dieleman S., and Willense A.H. Evidence of prolactin as the main luteotrophic factor in the cyclic dog. Vet Quart 12 (1990) 193-201
9. Wichtel J.J., Whitacre M.D., Yates D.J., and Van Camp S.D. Comparison of the effects of PGF2α and bromocriptine in pregnant beagle bitches. Theriogenology 338 (1990) 829-836
10. Post K., Evans L.E., and Jochle W. Effects of prolactin suppression with cabergoline on the pregnancy of the bitch. Theriogenology 29 (1988) 1233-1243
11. Nothling J.O., Gerber D., Gersnberg C., Kaiser C., and Dobeli M. Abortefacient and endocrine effects of metergoline in beagle bitches during the second half of gestation. Theriogenology 59 (2003) 1929-1940
12. Onclin K., Silva L.D.M., and Verstegen J.P. Termination of unwanted pregnancy in dogs with the dopamine agonist cabergoline, in combination with a synthetic analog of PGF2α, either cloprostenol or alpha prostol. Theriogenology 43 (1995) 813-822
13. Onclin K., and Verstegen J.P. Comparison of different combinations of analogues of PGF2α and dopamine agonists for the termination of pregnancy in dogs. Vet Rec 144 (1999) 416-419
14. Gobello C., Castex G., Corrada Y., Klima L., Sota L.D., and Rodriguez R. Use of prostaglandins and bromocriptine mesylate for pregnancy termination in bitches. J Am Vet Med Assoc 220 (2002) 1017-1019
15. Corrada Y., Arias D., Rodríguez R., Tortora M., and Gobello C. Combination dopamine agonist and prostaglandin agonist treatment of cystic endometrial hyperplasia-pyometra complex in the bitch. Theriogenology 66 (2006) 1557-1559
16. Donnay I., Rauis J., and Verstegen J. Influence des antécédents hormonaux sur l'apparition clinique des tumeurs mammaires chez la chienne. Étude épidemiologique. Ann Med Vet 138 (1994) 109-117
17. Verstegen J. Intérêt et applications des antiprolactiques en la cancérologie chez la chienne. Proceedings of the 24th World Small Animal Veterinary Congress, vol. 34 (1999) 187-189
18. Okkens A.C., Bevers M.M., Dieleman S.J., and Willemse A.H. Shortening of the interestrous interval of the cyclic dog by bromocriptine treatment. Vet Quart 7 (1985) 173-176
19. Jeukenne P., and Verstegen J. Termination of diestrus and induction of oestrus in diestrous non-pregnant bitches by the prolactin antagonist cabergoline. J Reprod Fertil 51 (1997) 59-66
20. Verstegen J., Onclin K., Silva L., and Concannon P. Effect of stage of anestrus on the induction of estrus by the dopamine agonist cabergoline in dogs. Theriogenology 51 (1999) 597-611
21. Arbeiter K., and Barsch E. Possibilities of oestrus induction in the bitch in than ergoline derivate. J Vet Med 35 (1988) 111-117
22. Gobello C., Castex G., and Corrada Y. Use of cabergoline to treat primary and secondary anestrus in dogs. J Am Vet Med Assoc 220 (2002) 1653-1654
23. Beijerink N.J., Dieleman S.J., Kooistra H.S., and Okkens A.C. Low doses of bromocriptine shorten the interestrous interval in the bitch without lowering plasma prolactin concentration. Theriogenology 60 (2003) 1379-1386
24. van Haaften B., Dieleman S.J., Okkens A.C., Bevers M.M., and Willemse A.H. Induction of estrus and ovulation in dogs by treatment with PMSG and/or bromocriptine. J Reprod Fertil Suppl 39 (1989) 330-331
25. Kusuma P.S.H., and Tainturier D. Comparison of induction of oestrus in dogs using metergoline, metergoline plus human chorionic gonadotrophin, or pregnant mare serum gonadotrophin. J Reprod Fertil 47 (1993) 363-370
26. Okkens A.C., Kooistra H.S., Dieleman S.J., and Bevers M.M. Dopamine agonistic effects as opposed to prolactin concentrations in plasma as the influencing factor on the duration of anoestrus in bitches. J Reprod Fertil 51 (1997) 55-58
27. Hoffmann B., Lemmer W., Bostedt H., and Failing K. Application of the anti-progestin aglepristone for the conservative treatment of pyometra in the dog. Tierarztl Prax 28 (2000) 323-329
28. Concannon P.W., Yeager A., Frank D., and Iyampillai A. Termination of pregnancy and induction of premature luteolysis by the anti-progestagen, mifepristone, in dogs. J Reprod Fertil 88 (1990) 99-104
29. Linde-Forsberg C., Kindhal H., and Madej A. Termination of mid-term pregnancy in the dog with oral RU 486. J Am Anim Pract 33 (1992) 331-336
30. Fieni F., Tainturier D., Bruyas J.F., Badinand F., Berthelot X., Ronsin P., et al. Etude clinique d'une anti-hormone pour provoquer l'avortement chez la chienne. Rec Med Vet 172 (1996) 359-367
31. 4 receptor antagonists. Theriogenology 53 (2000) 941-950
32. Fieni F., Martal J., Marnet P.G., Siliart B., Bernards F., Rio M., et al. Hormonal variation after early and mid pregnancy termination in bitches with aglepristone (RU 534). J Reprod Fertil Suppl 57 (2001) 243-248
33. Nohr B., Hoffmann B., and Steinetz B.E. Investigation of the endocrine control of parturition in the dog by application of an antigestagen. J Reprod Fertil Suppl 47 (1993) 542-543
34. 4 antagonist aglepristone (RU 534) to induce parturition in bitches. J Reprod Fertil Suppl 57 (2001) 237-242
35. Riesemberk A., Klein R., Hoffmann B., and Hospes R. Geburtsinduktion infolge verlamgerter graviditat bei einer hundin unter verwendung eines antigestagens. Tierarztl Prax 27 (1999) 186-188
36. Blendinger K., Bostedt H., and Hoffmann B. Hormonal effects of the use of an anti-progestin in bitches with pyometra. J Reprod Fertil Suppl 51 (1997) 317-325
37. Breitkopt M., Hoffmann B., and Bostedt H. Treatment of pyometra in bitches with an anti-progestin. J Reprod Fertil Suppl 51 (1997) 327-331
38. Hoffmann B., Lemmer W., Bostedt H., and Failing K. Application of the anti-progestin aglepristone for the conservative treatment of pyometra in the dog. Tierarztl Prax 28 (2000) 323-329
39. Fieni F., Bruyas D., Tainturier D., and Battut I. Clinical use of anti-progestins in the treatment of metritis/pyometra in the bitch. Proceedings of the 5th Annual Conference of the European Society of Domestic Animal Reproduction (2001) CD
40. Gobello C., Castex C., Klima L., Rodríguez R., and Corrada Y. A study of two combined protocols of aglepristone and cloprostenol to treat open cervix pyometra in the bitch. Theriogenology 60 (2003) 901-908
41. Trasch K., Wehrend A., and Bostedt H. Follow up examinations of bitches after conservative treatment of pyometra with the antigestagen aglepristone. J Vet Med Assoc 50 (2003) 375-379
42. Bamberg-Thalen B., and Linde-Forsberg C. The effects of medroxyprogesterone acetate and ethinylestradiol on hemogram, prostate, testes and semen quality in normal dogs. J Vet Med Assoc 39 (1992) 264-270
43. Corrada Y., Spaini E., Fava F., Arias D., Rodríguez R., and Gobello C. Effect of tamoxifen citrate on reproductive parameters of male dogs. Theriogenology 61 (2004) 1327-1341
44. Bamberg-Thalen B., and Linde-Forsberg C. Treatment of canine benign prostatic hyperplasia with medroxyprogesterone acetate. J Am Anim Hosp Assoc 29 (1993) 221-226
45. Linde-Forsberg C., and Bamberg-Thalen B.S. Effects of medroxyprogesterone acetate on semen quality of the dog. Proceedings of the 3rd International Symposium on Reproduction of Dogs, Cats and Exotic Carnivores (1996) 1
46. England G.C. Effects of progestins and androgens upon spermatogenesis and steroidogenesis in dogs. J Reprod Fertil 51 (1997) 123-138
47. Tunn U., Senge T., Shenck B., and Nuemann F. Biochemical and histological studies on prostates in castrated dogs after treatment with androstenodiol, estradiol and cyproterone acetate. Acta Endocrinol 91 (1979) 373-384
48. Brass W., Ficus H.J., and Jochle W. Anti-androgen treatment of prostate enlargement in male dogs. Kleintierpraxis 16 (1971) 95-99
49. Orima H., Shimizu M., and Tsuitsui T. Short term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate. J Vet Med Sci 57 (1995) 139-341
50. Neri R.O., and Monahan M. Effects of a novel noesteroideal anti-androgen on canine prostatic hyperplasia. Invest Urol 10 (1972) 123-130
51. Kazuto I., Yoshitatsu F., Yasuhiro S., Kasuhiro S., Mamoru M., Kohtaro G., et al. Effects of a new steroideal aromatase inhibitor, TZA-2237, and/or chlormalidone acetate on hormone induced and spontaneous benign prostatic hyperplasia. Eur J Endocrinol 143 (2000) 543-554
52. Cohen S.M., Werrmann J.G., Rasmusson G.H., Tanaka W.K., Malatesta P.F., Prahalada S., et al. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression. Prostate 26 (1995) 55-71
53. Iguer-Ouada M., and Verstegen J.P. Effect of finasteride (Proscar MSD) on seminal composition, prostate function and fertility in male dogs. J Reprod Fertil 51 (1997) 139-149
54. Kamolpatana K. Effect of finasteride on benign prostatic hypertrophy in dogs. PhD Thesis, Washington State University, Pullman, WA. 1998. p. 153.
55. Sirinarumitr K., Johnston S.D., Root-Kustritz M.V., Johnston G.R., Sarkar D.K., and Memon M.A. Effects of finasteride on size of the prostate gland and semen quality in dogs with benign prostatic hypertrophy. J Am Vet Assoc 218 (2001) 1275-1280
56. Mc Rae G.I., Roberts B.B., Worden A.C., Bajka A., and Vickery B.H. Long term reversible suppression of estrus in bitches with nafarelin acetate, a potent LHRH agonist. J Reprod Fertil 74 (1985) 389-397
57. Vickery B.H., Mc Rae G.I., Goodpasture J.C., and Sanders L.M. Use of potent LHRH analogues for chronic contraception and pregnancy termination. J Reprod Fertil 39 (1989) 175-187
58. Inaba T., Umerhara T., Mori J., Torri R., Tani H., Gonda M., et al. Reversible suppression of pituitary testicular function by a sustained release formulation of GnRH agonist (leuprolide acetate) in dogs. Theriogenology 46 (1996) 671-677
59. Gobello C., Corrada Y., and Trigg T. Reversible prolongation of anestrus in the bitch with deslorelin acetate. Rev Bras Reprod Anim 27 (2003) 518-519
60. Trigg T.E., Wright P.J., Armour A.F., Williamson P.E., Junaidi A., Martin G.B., et al. Use of a GnRH analogue implant to produce reversible, long term suppression of reproductive function of male and female domestic dogs. J Reprod Fertil 57 (2001) 255-261
61. Ponglowhapan S., Lohachit C., Swangchanuthai T., and Trigg T.E. The effect the GnRH agonist deslorelin on prostatic volume in dogs. Proceedings of the 3rd EVSSAR Meeting (2002) 150
62. Riesenbeck A., Klein R., and Hoffmann B. Down-regulation, a new and reversible approach to eliminate testicular function in the dog. De Praktische Tierarzt 83 (2002) 512-520
63. 10] GnRH ethylamide. J Androl 10 (1989) 456-465
64. Rubion S., Guerin C., Crivieri-Godet E., Horspool L., Rutten F., and Driancourt M.A. Treatment with a subcutaneous GnRH agonist containing devise suppresses FSH and ovarian function in bitches. Reprod Dom Anim 79 (2003) 355 (abstr)
65. Wright P.J., Verstegen J.P., Onclin K., Jochle W.J., Armour A.F., Martin G.B., et al. The suppression by progestin of oestrus responses of the bitch to the GnRH analogue deslorelin. J Reprod Fertil 57 (2001) 263-268
66. Lombardi P., Florio S., Pagnini U., Crispido A., and Avallone L. Ovarian function suppression with a GnRH analogue goserelin in hormone dependent canine mammary gland cancer. J Vet Pharmacol Therap 22 (1999) 56-61
67. Inaba T., Tani H., Gonda M., Nakagawa A., Ohmura M., Mori J., et al. Induction of fertile estrus using a sustained release formulation of a GnRH agonists (leuprolide acetate). Theriogenology 49 (1998) 975-982
68. Kutzler M.A., Wheeler R., Lamb S.V., and Volkmann D.H. Deslorelin implant administration beneath the vulvar mucosa for the induction of synchronous estrus in bitches. Proceedings of the 3rd EVSSAR Meeting (2002) 96
69. Kutzler M.A., Wheeler R., and Volkmann D.H. Deslorelin implants for induction of estrus in bitches. Proceedings of the 2nd EVSSAR Meeting (2001) 160-161
70. Willams C.L., and Stancel G.M. Estrogens and progestins. In: Herdman J.J., Limbird L.E., and Goodman Gilman A. (Eds). Goodman and Gilman's: the pharmacological basis of therapeutics. 9th ed. (1996), Goodman & Gilman, New York 1489-1529
71. Jordan V.C. The role of tamoxifen in the treatment and prevention of breast cancer. Curr Prob Cancer 16 (1992) 129-176
72. Melk Y.A., Belisle S., Carmel M., and Tetreault J.P. Tamoxifen citrate in male infertility. Fertil Steril 48 (1987) 113-117
73. Bowen R.A., Olson P.N., Young S., and Withhrow S.J. Efficacy and toxicity of tamoxifen for prevention and termination of pregnancy in bitches. Am J Vet Res 49 (1988) 27-31
74. Corrada Y., Arias D., Rodríguez R., Spaini, Fava F., and Gobello C. Effect of tamoxifen citrate on reproductive parameters of male dogs. Theriogenology 61 (2004) 1327-1341
75. Kitchell B.E., and Fidel J.L. Tamoxifen as a potential therapy for canine mammary carcinoma. Proceedings of the Vet Can Soc (1992) 91
76. Morris J.S., Dobson J.M., and Bostock D.E. Use of tamoxifen in the control of canine mammary neoplasia. Gynecol Oncol 39 (1993) 82-84
77. Gobello C., and Del Amo A. Estrus induction with clomiphene citrate in bitches. Proceedings of the 1st International Congress FCV-UNLP and 7th International Veterinary Meeting (1993) 4-6